AIM ImmunoTech Inc. — Director's Dealing 2019

Oct 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2019-10-02

Reporting Person: APPELROUTH STEWART (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-02	Common Stock	J	5002	$0.76	Acquired	40687	Direct

Footnotes

F1: Shares issued for 50 percent of Director's Fee for the second half of September, 2019.